Silvia Pérez

737 total citations
17 papers, 141 citations indexed

About

Silvia Pérez is a scholar working on Rheumatology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silvia Pérez has authored 17 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Immunology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silvia Pérez's work include Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Silvia Pérez is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Atherosclerosis and Cardiovascular Diseases (4 papers). Silvia Pérez collaborates with scholars based in Spain and Colombia. Silvia Pérez's co-authors include Patricia Aspichueta, Begoña Ochoa, Yolanda Chico, Miguel Á. González‐Gay, Santos Castañeda, Olatz Fresnedo, Isidoro González‐Álvaro, José A. Miranda‐Filloy, Esther Toledano and Ana M. Ortiz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Transplantation and Atherosclerosis.

In The Last Decade

Silvia Pérez

16 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Pérez Spain 8 51 46 40 38 22 17 141
Dina Ramadan Kuwait 12 36 0.7× 47 1.0× 26 0.7× 99 2.6× 12 0.5× 19 273
Andrew D. Johnson United States 6 32 0.6× 10 0.2× 41 1.0× 81 2.1× 43 2.0× 9 242
Thomas Ness United Kingdom 5 123 2.4× 23 0.5× 28 0.7× 53 1.4× 17 0.8× 8 248
Jazmín Calyeca United States 6 35 0.7× 25 0.5× 10 0.3× 88 2.3× 24 1.1× 10 261
Luciano Ibba Italy 10 33 0.6× 133 2.9× 47 1.2× 29 0.8× 18 0.8× 36 264
Jan Klocke Germany 8 12 0.2× 117 2.5× 113 2.8× 56 1.5× 14 0.6× 15 275
Yongfu Wang China 8 22 0.4× 44 1.0× 37 0.9× 85 2.2× 20 0.9× 23 270
Weiqing Song China 10 15 0.3× 139 3.0× 46 1.1× 84 2.2× 47 2.1× 25 318
Saeko Yamada Japan 9 51 1.0× 42 0.9× 50 1.3× 35 0.9× 12 0.5× 20 165
Qimin Ng United States 4 14 0.3× 147 3.2× 65 1.6× 32 0.8× 12 0.5× 9 200

Countries citing papers authored by Silvia Pérez

Since Specialization
Citations

This map shows the geographic impact of Silvia Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Pérez more than expected).

Fields of papers citing papers by Silvia Pérez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Pérez. The network helps show where Silvia Pérez may publish in the future.

Co-authorship network of co-authors of Silvia Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Pérez. A scholar is included among the top collaborators of Silvia Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Pérez. Silvia Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ferrán, Marta, Mar Llamas‐Velasco, E. del Alcázar, et al.. (2022). Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group. Dermatologic Therapy. 35(11). e15865–e15865. 10 indexed citations
2.
Boteanu, Alina, Leticia León, Silvia Pérez, et al.. (2022). Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry. Modern Rheumatology. 34(1). 97–105. 4 indexed citations
3.
Boteanu, Alina, Olga Sánchez‐Pernaute, Silvia Pérez, et al.. (2021). POS1260 FACTORS ASSOCIATED WITH SEVERE SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES IN MADRID: RESULTS FROM REUMA-COVID SORCOM REGISTRY. Annals of the Rheumatic Diseases. 80. 914–914. 1 indexed citations
4.
Ortiz, Ana M., Silvia Pérez, Esther Toledano, et al.. (2020). Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?. Arthritis Research & Therapy. 22(1). 213–213. 12 indexed citations
6.
Deza, Gustavo, J. Notario, Marta Ferrán, et al.. (2018). Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain. Rheumatology International. 38(11). 2037–2043. 3 indexed citations
7.
Pérez, Silvia, Miguel Á. González‐Gay, & Santos Castañeda. (2013). Actualización terapéutica en las vasculitis de grandes vasos. Revista Clínica Española. 213(7). 338–346. 7 indexed citations
8.
Pérez, Silvia, Miguel Á. González‐Gay, & Santos Castañeda. (2013). Therapeutic update in large vessel vasculitides. Revista Clínica Española (English Edition). 213(7). 338–346. 5 indexed citations
9.
Pérez, Silvia, et al.. (2013). AB0462 Large vessel vasculitis refractory to conventional therapy. experience with tocilizumab.. Annals of the Rheumatic Diseases. 72. A929–A930. 1 indexed citations
10.
Pérez, Silvia & Gabriel Herrero‐Beaumont. (2013). Osteoimmunology, Osteorheumatology or Rheumatology Alone?. Reumatología Clínica (English Edition). 9(5). 257–258. 1 indexed citations
11.
García-Bermúdez, Mercedes, Carlos González‐Juanatey, Raquel López‐Mejías, et al.. (2012). AB0022 Influence of mhciita RS3087456 and RS4774 polymorphisms in the susceptibility to cardiovascular disease of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 71. 638–638. 1 indexed citations
12.
Caballero, Pedro, et al.. (2012). Actualización en fascitis necrotizante. 13(2). 41–48. 7 indexed citations
13.
García-Bermúdez, Mercedes, C González-Juanatey, Luis Rodríguez‐Rodríguez, et al.. (2011). Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis.. PubMed. 29(4). 681–8. 12 indexed citations
14.
López‐Mejías, Raquel, Mercedes García-Bermúdez, Carlos González‐Juanatey, et al.. (2011). Lack of association between IL6 single nucleotide polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Atherosclerosis. 219(2). 655–658. 18 indexed citations
15.
Aspichueta, Patricia, et al.. (2006). Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver. Journal of Endotoxin Research. 12(3). 181–192. 12 indexed citations
16.
Pérez, Silvia, Patricia Aspichueta, Begoña Ochoa, & Yolanda Chico. (2006). The 2-series prostaglandins suppress VLDL secretion in an inflammatory condition-dependent manner in primary rat hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(2). 160–171. 37 indexed citations
17.
Aspichueta, Patricia, et al.. (2006). Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver. Journal of Endotoxin Research. 12(3). 181–191. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026